Urszula Dougherty

3.4k total citations · 2 hit papers
53 papers, 2.3k citations indexed

About

Urszula Dougherty is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Urszula Dougherty has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Urszula Dougherty's work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (7 papers). Urszula Dougherty is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (7 papers). Urszula Dougherty collaborates with scholars based in United States, China and Canada. Urszula Dougherty's co-authors include Marc Bissonnette, Renbao Chang, Dali Han, Marc B. Bissonnette, Chuanyuan Chen, Yi Liu, Meng Xu, Reba Mustafi, Joel Pekow and John Hart and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Urszula Dougherty

52 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells

2019 737 citations Dali Han, Chuanyuan Chen et al. Nature profile →
The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth

2021 201 citations Chuanyuan Chen, Yawei Zhang et al. Cancer Cell profile →

Peers

Urszula Dougherty

ONCOL

IMMUN

PFM

Qinong Ye China

Chunxiao Liu China

Junchao Cai China

Xiaoyan Xin China

Peng Qi China

Minmin Shi China

Chifumi Fujii Japan

Xinchen Sun China

Peizhen Hu China

Xuelai Luo China

Qinong Ye China

Urszula Dougherty

2.1k ×1.4

1.2k ×1.4

536 ×1.1

ONCOL

229 ×0.7

IMMUN

153 ×0.5

PFM

Citations per year, relative to Urszula Dougherty Urszula Dougherty (= 1×) peers Qinong Ye

Countries citing papers authored by Urszula Dougherty

Since Specialization

Citations

This map shows the geographic impact of Urszula Dougherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urszula Dougherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urszula Dougherty more than expected).

Fields of papers citing papers by Urszula Dougherty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urszula Dougherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urszula Dougherty. The network helps show where Urszula Dougherty may publish in the future.

Co-authorship network of co-authors of Urszula Dougherty

This figure shows the co-authorship network connecting the top 25 collaborators of Urszula Dougherty. A scholar is included among the top collaborators of Urszula Dougherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urszula Dougherty. Urszula Dougherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

West-Szymanski, Diana C., Zhou Zhang, Xiaolong Cui, et al.. (2024). 5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. JCO Precision Oncology. 8(8). e2400277–e2400277. 1 indexed citations

Zeng, Shuai, Zhen Lyu, Wei Zhang, et al.. (2021). Epigenetic DNA Modifications Upregulate SPRY2 in Human Colorectal Cancers. Cells. 10(10). 2632–2632. 4 indexed citations

Chen, Chuanyuan, Yawei Zhang, Zhenghang Wang, et al.. (2021). The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth. Cancer Cell. 39(7). 945–957.e10. 201 indexed citations breakdown →

Zhang, Wei, Xu Zhang, Shuai Zeng, et al.. (2020). Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but not Decreased Promoter Methylation in Colorectal Cancer. Cancers. 12(3). 539–539. 15 indexed citations

Dougherty, Urszula, Reba Mustafi, Jeffrey S. Souris, et al.. (2019). Losartan and Vitamin D Inhibit Colonic Tumor Development in a Conditional Apc-Deleted Mouse Model of Sporadic Colon Cancer. Cancer Prevention Research. 12(7). 433–448. 3 indexed citations

Liu, Jianjun, Liu Y, Jaw‐Yuan Wang, et al.. (2019). Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells (vol 566, pg 270, 2019). Nature. 568(7751). 1 indexed citations

Eshein, Adam, Vesta Valuckaite, Urszula Dougherty, et al.. (2018). Early increase in blood supply (EIBS) is associated with tumor risk in the Azoxymethane model of colon cancer. BMC Cancer. 18(1). 814–814. 5 indexed citations

Pekow, Joel, Katherine Meckel, Urszula Dougherty, et al.. (2017). miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis–Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD. Clinical Cancer Research. 23(17). 5281–5291. 72 indexed citations

Chen, Nai‐Tzu, Jeffrey S. Souris, Shih‐Hsun Cheng, et al.. (2017). Lectin-functionalized mesoporous silica nanoparticles for endoscopic detection of premalignant colonic lesions. Nanomedicine Nanotechnology Biology and Medicine. 13(6). 1941–1952. 37 indexed citations

10.

Mustafi, Reba, Urszula Dougherty, Devkumar Mustafi, et al.. (2016). ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer. Clinical Cancer Research. 23(2). 549–561. 36 indexed citations

11.

Mustafi, Devkumar, Jesse Ward, Urszula Dougherty, et al.. (2015). XFM demonstrates preferential accumulation of a vanadyl-based MRI contrast agent in murine colonic tumors. Molecular Imaging. 14. 1 indexed citations

12.

Grimm, Wesley A., Jeannette S. Messer, Stephen F. Murphy, et al.. (2015). The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon. Gut. 65(3). 456–464. 71 indexed citations

13.

Dougherty, Urszula, Reba Mustafi, Devkumar Mustafi, et al.. (2014). The Renin–Angiotensin System Mediates EGF Receptor–Vitamin D Receptor Cross-Talk in Colitis-Associated Colon Cancer. Clinical Cancer Research. 20(22). 5848–5859. 36 indexed citations

14.

Liu, Weicheng, Yunzi Chen, Maya Aharoni Golan, et al.. (2013). Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. Journal of Clinical Investigation. 123(9). 3983–3996. 268 indexed citations

15.

Pekow, Joel, Urszula Dougherty, Yong Huang, et al.. (2013). Gene Signature Distinguishes Patients with Chronic Ulcerative Colitis Harboring Remote Neoplastic Lesions. Inflammatory Bowel Diseases. 19(3). 461–470. 39 indexed citations

16.

Dougherty, Urszula, Victoria Robinson, Reba Mustafi, et al.. (2011). EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators. Molecular Cancer Research. 9(7). 960–975. 96 indexed citations

17.

Dougherty, Urszula, Masha Kocherginsky, Amikar Sehdev, et al.. (2009). Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor- and PTGS2. Clinical Cancer Research. 15(22). 6780–6789. 30 indexed citations

18.

Dougherty, Urszula, Amikar Sehdev, Sandra Cerda, et al.. (2008). Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model. Clinical Cancer Research. 14(8). 2253–2262. 48 indexed citations

19.

Fichera, Alessandro, Sujatha Jagadeeswaran, Urszula Dougherty, et al.. (2007). Epidermal Growth Factor Receptor Signaling Is Required for Microadenoma Formation in the Mouse Azoxymethane Model of Colonic Carcinogenesis. Cancer Research. 67(2). 827–835. 47 indexed citations

20.

Cohen, Greg, Reba Mustafi, Sandra Cerda, et al.. (2006). Epidermal Growth Factor Receptor Signaling Is Up-regulated in Human Colonic Aberrant Crypt Foci. Cancer Research. 66(11). 5656–5664. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact